Study on Management Thrombosis in Greek Cancer Patients

N/ACompletedNCT03292107

Hellenic Society of Medical Oncology500 enrolled

Overview

Study on Management Thrombosis in Greek cancer patients

The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Thrombosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria * All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline. * Age ≥ 18 years * Signed informed consent Exclusion Criteria * Initiation of anticoagulation therapy before the initiation of the study in 2016 * Age \<18 years * No signed informed consent

Locations (1)

Hellenic Society of Medical Oncology

Athens, Greece

Outcomes

Primary Outcomes

The clinical practice for patients under anticoagulation regime

Documentation of the clinical practice for patients under anticoagulation regime, for prophylaxis or treatment, in patients with solid tumors, for one year following the protocol initiation date, including high-risk patients as defined in the protocol.

Time frame: 1 YEAR

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.